European Leukemia Trial Registry
Trial: Gilead-US-354-0101

More Details
Title Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
Scientific Title A Phase 2, Open-label, Randomized Study to Evaluate the Safety and Efficacy of Momelotinib in Subjects With Polycythemia Vera or Essential Thrombocythemia
Short Title Gilead-US-354-0101
Trialgroup NN
Type of Trial randomized, open-label
Disease Myeloproliferative disease(MPD) Polycythaemia vera
Myeloproliferative disease(MPD) Essential Thrombocythaemia
Age >= 18 years
Status Active
Start of Recruitment 25.11.2013
Shortprotocol Shortprotocol
Remark Endpunkt: Gesamtansprechrate
created 03.09.2014 Johannes Kraus
changed 28.11.2014 Hanna Ebert
ELIC European Leukemia Information Center | no responsibility is taken for correctness and completeness of this information | www.leukemia-net.org | elic@leukemia-net.org